Unknown OBSERVATIONAL NCT02859363

Fabry Disease in Cerebrovascular Disease

Improving the Diagnostic Rate of Fabry Disease in Patients With Cerebrovascular Involvement in Taiwan- a Cohort Screening Program

Sponsor: Chang Gung Memorial Hospital

Conditions Fabry Disease

Interventions 26 common Fabry mutation types in Taiwan

Updated 7 times since 2017 Last updated: Aug 9, 2016 Started: Mar 31, 2016 Primary completion: Mar 31, 2017 Completion: Aug 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Fabry Disease and is currently ongoing. Chang Gung Memorial Hospital leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Sep 2018 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2018 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chang Gung Memorial Hospital
Sanofi

Data source: Chang Gung Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kweishan, Taiwan